STANDARD BIOTOOLS INC. (LAB) Return on equity 2016–2025
STANDARD BIOTOOLS INC. (LAB) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-17.7%FY2025 · since FY2016: -142.7% → -17.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -17.7% | +11.8 pp |
| FY2024 | -29.4% | — |
| FY2021 | -62.6% | -24.5 pp |
| FY2020 | -38.1% | +4.0 pp |
| FY2019 | -42.2% | +39.7 pp |
| FY2018 | -81.8% | +113.9 pp |
| FY2017 | -195.7% | -52.9 pp |
| FY2016 | -142.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice